Valuation: Stryker Corporation

Market Cap 127B 111B 103B 94.18B 178B 12,235B 181B 1,224B 481B 5,975B 477B 466B 20,627B P/E 2026 *
26.1x
P/E 2027 * 22.8x
Enterprise Value 136B 119B 110B 101B 191B 13,084B 194B 1,309B 514B 6,389B 510B 499B 22,058B EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.48x
Free-Float
94.62%
Yield 2026 *
1.09%
Yield 2027 * 1.16%
1 day+7.09%
1 week+2.26%
1 month+8.80%
1 week 12.7
Extreme 12.7
14.4
1 month 12.3
Extreme 12.3
14.4
Current year 12
Extreme 12
14.4
1 year 12
Extreme 12
14.4
3 years 12
Extreme 12
14.4
5 years 12
Extreme 12
14.4
10 years 12
Extreme 12
14.4
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2012
Director of Finance/CFO 50 31/03/2025
President 49 31/12/2025
Director TitleAgeSince
Director/Board Member 82 31/12/1973
Director/Board Member 71 31/12/1983
Chairman 60 21/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
+7.09%+2.26% - - 121B
+1.04%+2.87%+6.06%-1.44% 13.07B
-0.92%+0.21%+57.76%+96.47% 9.21B
+3.39%+13.56%-44.10%-69.82% 4.2B
-1.12%+6.05%+16.01%+52.41% 2.91B
-0.07%-0.41%-17.30%-27.09% 1.73B
+0.73%+5.10%-2.93%-19.41% 1.67B
+9.69%+11.30%-8.09%-56.97% 1.47B
+2.06%+0.04%-59.58%-84.19% 1.46B
Average +2.43%+4.49%-6.52%-13.76% 4.46B
Weighted average by Cap. +5.70%+3.94%+9.49%+12.40%

Financials

2026 *2027 *
Net sales 27.27B 23.84B 22.04B 20.23B 38.29B 2,628B 38.95B 263B 103B 1,283B 102B 100B 4,430B 29.59B 25.86B 23.92B 21.95B 41.54B 2,851B 42.26B 285B 112B 1,392B 111B 109B 4,807B
Net income 4.84B 4.23B 3.92B 3.59B 6.8B 467B 6.92B 46.7B 18.35B 228B 18.19B 17.79B 787B 5.54B 4.85B 4.48B 4.11B 7.78B 534B 7.92B 53.44B 20.99B 261B 20.82B 20.36B 901B
Net Debt 8.81B 7.7B 7.12B 6.54B 12.37B 849B 12.59B 84.96B 33.38B 415B 33.1B 32.37B 1,432B 5.54B 4.84B 4.47B 4.11B 7.77B 533B 7.91B 53.36B 20.96B 260B 20.79B 20.33B 899B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change
16/07/26 €13.60 +7.09%
15/07/26 €12.70 -7.30%
14/07/26 €13.70 -4.86%
13/07/26 €14.40 +8.27%
10/07/26 €13.30 0.00%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
331.20USD
Average target price
386.52USD
Spread / Average Target
+16.70%

Quarterly revenue - Rate of surprise